https://www.selleckchem.com/products/tas-102.html
A total of four patients with a median age of 34 years (range 24 - 51) who were observed over an average of 26.5 months (range 17 - 49 months) matched our inclusion criteria. We appreciated stabilization or increase in visual acuity in all four patients and a regression in tumour thickness with subsequent increase in internal reflectivity as a marker of increasing fibrosis. We observed good visual and functional outcome following CyberKnife therapy for VPT. We believe that further studies should be pursued to evaluate CyberKnife therapy
Curtir
Comentario
Compartilhar
